Department of Biomedical Engineering, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, the Netherlands.
Department of Vascular Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands.
J Vasc Access. 2024 Sep;25(5):1584-1592. doi: 10.1177/11297298231180627. Epub 2023 Jun 19.
Clinical guidelines provide recommendations on the minimal blood vessel diameters required for arteriovenous fistula creation but the evidence for these recommendations is limited. We compared vascular access outcomes of fistulas created in agreement with the ESVS Clinical Practice Guidelines (i.e. arteries and veins >2 mm for forearm fistulas and >3 mm for upper arm fistulas) with fistulas created outside these recommendations.
The multicenter Shunt Simulation Study cohort contains 211 hemodialysis patients who received a first radiocephalic, brachiocephalic, or brachiobasilic fistula before publication of the ESVS Clinical Practice Guidelines. All patients had preoperative duplex ultrasound measurements according to a standardized protocol. Outcomes included duplex ultrasound findings at 6 weeks after surgery, vascular access function, and intervention rates until 1 year after surgery.
In 55% of patients, fistulas were created in agreement with the ESVS Clinical Practice Guidelines recommendations on minimal blood vessel diameters. Concordance with the guideline recommendations was more frequent for forearm fistulas than for upper arm fistulas (65% vs 46%, = 0.01). In the entire cohort, agreement with the guideline recommendations was not associated with an increased proportion of functional vascular accesses (70% vs 66% for fistulas created within and outside guideline recommendations, respectively; = 0.61) or with decreased access-related intervention rates (1.45 vs 1.68 per patient-year, = 0.20). In forearm fistulas, however, only 52% of arteriovenous fistulas created outside these recommendations developed into a timely functional vascular access.
Whereas upper arm arteriovenous fistulas with preoperative blood vessel diameters <3 mm had similar vascular access function as fistulas created with larger blood vessels, forearm arteriovenous fistulas with preoperative blood vessel diameters <2 mm had poor clinical outcomes. These results support that clinical decision-making should be guided by an individual approach.
临床指南提供了创建动静脉瘘所需的最小血管直径的建议,但这些建议的证据有限。我们比较了符合 ESVS 临床实践指南(即前臂瘘管的动脉和静脉>2mm,上臂瘘管的动脉和静脉>3mm)创建的血管通路结果与超出这些建议创建的瘘管。
多中心分流模拟研究队列包含 211 名接受首次桡头、肱头或肱骨干动静脉瘘的血液透析患者,这些患者在 ESVS 临床实践指南发布之前接受了手术。所有患者均根据标准化方案进行术前双功超声测量。结果包括术后 6 周的双功超声检查结果、血管通路功能和术后 1 年的干预率。
在 55%的患者中,瘘管的创建符合 ESVS 临床实践指南对最小血管直径的建议。与上臂瘘管相比,前臂瘘管更符合指南建议(65%比 46%, = 0.01)。在整个队列中,符合指南建议与增加功能血管通路的比例无关(分别为在指南建议内和外创建的瘘管为 70%和 66%, = 0.61),也与减少与通路相关的干预率无关(分别为每患者年 1.45 和 1.68, = 0.20)。然而,在不在这些建议范围内的前臂瘘管中,只有 52%及时形成了功能血管通路。
尽管术前血管直径<3mm 的上臂动静脉瘘具有相似的血管通路功能,但与较大血管创建的瘘管相比,术前血管直径<2mm 的前臂动静脉瘘临床结局较差。这些结果支持以个体化方法指导临床决策。